-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Mitochondria and Metabolism - Blood Cancer Clinical Trials

Symposia: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients Program: Scientific Workshops
Friday, December 8, 2023: 4:10 PM-4:55 PM
Room 24 (San Diego Convention Center)
Moderator:
and Marina Y. Konopleva, Albert Einstein College of Medicine
Disclosures:
Konopleva: Reata Pharmaceuticals.: Current holder of stock options in a privately-held company, Patents & Royalties; AbbVie, AstraZeneca, Genentech, Gilead, Janssen, MEI Pharma, Sanofi Aventis, Stemline-Menarini, Vincerx: Consultancy; AbbVie, Ablynx, Allogene, AstraZeneca, Cellectis, Daiichi, FortySeven, Genentech, Gilead, Immunogen, MEI Pharma, Precision Biosciences, Rafael Pharmaceutical, Sanofi Aventis, Stemline-Menarini: Research Funding.
Moderator Introduction

Marina Y. Konopleva

Albert Einstein College of Medicine, Bronx, NY
Targeting Mitochondrial Metabolism in Acute Myeloid Leukemia, Lessons Learned

Timothy S Pardee, MD, PhD

Comprehensive Cancer Center of Atrium Health Wake Forest Baptist, Winston-Salem, NC
Q+A

Timothy S Pardee, MD, PhD

Wake Forest University, Winston-Salem, NC
Mitochondrial Ferroptosis in Acute Myeloid Leukemia

Michael Andreeff, MD PhD

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Q+A

Michael Andreeff, MD PhD

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Panel Discussion
See more of: Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
See more of: Scientific Workshops
<< Previous Session | Next Session >>